179 related articles for article (PubMed ID: 33497517)
1. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
Cazzaniga M; Fumagalli LAM; D'angelo L; Cerino M; Bonfanti G; Fumagalli RM; Schiavo G; Lorini C; Lainu E; Terragni S; Chiarelli M; Scarazzati C; Bonato C; Zago M
Int J Clin Pract; 2021 Jul; 75(7):e14047. PubMed ID: 33497517
[TBL] [Abstract][Full Text] [Related]
2. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
[TBL] [Abstract][Full Text] [Related]
4. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID-19 infection.
Krishnamurthy V; Sujatha KJ; Kumar TA; Phaniraj P; Shankar T; Raj MP
Ann Afr Med; 2022; 21(3):278-282. PubMed ID: 36204916
[TBL] [Abstract][Full Text] [Related]
5. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
[TBL] [Abstract][Full Text] [Related]
6. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.
P P; Krishnamurthy V; Kumar TA
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443507
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.
Eijmael M; Janssens N; le Cessie S; van Dooren Y; Koster T; Karim F
Infection; 2021 Dec; 49(6):1325-1329. PubMed ID: 34625911
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
Front Immunol; 2021; 12():668074. PubMed ID: 34149705
[TBL] [Abstract][Full Text] [Related]
9. Eosinopenia and post-hospital outcomes in critically ill non-cardiac vascular surgery patients.
von Meijenfeldt GCI; Chary S; van der Laan MJ; Zeebregts CJAM; Christopher KB
Nutr Metab Cardiovasc Dis; 2019 Aug; 29(8):847-855. PubMed ID: 31248714
[TBL] [Abstract][Full Text] [Related]
10. Absolute Eosinophil Count Predicts Intensive Care Unit Transfer Among Elderly COVID-19 Patients From General Isolation Wards.
Huang J; Zhang Z; Liu S; Gong C; Chen L; Ai G; Zhu X; Zhang C; Li D
Front Med (Lausanne); 2020; 7():585222. PubMed ID: 33251234
[No Abstract] [Full Text] [Related]
11. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
12. Eosinopenia as Predictor of Poor Outcome in Hospitalized COVID-19 Adult Patients from Waves 1 and 2 of 2020 Pandemic.
Cauchois R; Pietri L; Dalmas JB; Koubi M; Capron T; Cassir N; Potere N; Polidoro I; Jean R; Jarrot PA; Andre B; Veit V; Carvelli J; Pauly V; Chanez P; Papazian L; Kaplanski G
Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557676
[TBL] [Abstract][Full Text] [Related]
13. Eosinopenia Predicting Long-term Mortality in Hospitalized Acute Exacerbation of COPD Patients with Community-acquired Pneumonia-A Retrospective Analysis.
Mao Y; Qian Y; Sun X; Li N; Huang H
Int J Chron Obstruct Pulmon Dis; 2021; 16():3551-3559. PubMed ID: 35002227
[TBL] [Abstract][Full Text] [Related]
14. Eosinopenia and COVID-19.
Tanni F; Akker E; Zaman MM; Figueroa N; Tharian B; Hupart KH
J Am Osteopath Assoc; 2020 Jul; ():. PubMed ID: 32672799
[TBL] [Abstract][Full Text] [Related]
15. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalised paediatric and adult patients: a case-control study.
Wibrow BA; Ho KM; Flexman JP; Keil AD; Kohrs DL
Anaesth Intensive Care; 2011 Mar; 39(2):224-30. PubMed ID: 21485670
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].
Li YX; Wu W; Yang T; Zhou W; Fu YM; Feng QM; Ye JM
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):372-374. PubMed ID: 32370466
[TBL] [Abstract][Full Text] [Related]
18. Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients Presenting with Acute Myocardial Infarction.
Alkhalil M; Kearney A; Hegarty M; Stewart C; Devlin P; Owens CG; Spence MS
Am J Med; 2019 Dec; 132(12):e827-e834. PubMed ID: 31152721
[TBL] [Abstract][Full Text] [Related]
19. Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study.
Wang X; Dian Y; Zhou Q; Deng G; Wei R; Zeng F
Front Immunol; 2023; 14():1320973. PubMed ID: 38162638
[TBL] [Abstract][Full Text] [Related]
20. Eosinopenia as a predictor of unexpected re-admission and mortality after intensive care unit discharge.
Yip B; Ho KM
Anaesth Intensive Care; 2013 Mar; 41(2):231-41. PubMed ID: 23530790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
